Recognizing and reversing the immunosuppressive tumor microenvironment of head and neck cancer

Keyphrases

• Head-and-neck Squamous Cell Carcinoma (HNSCC) 100%
• Head-and-neck Cancer 100%
• Immunosuppressive Microenvironment 100%
• Tumor Microenvironment 66%
• Antitumor Immune Response 66%
• United States 33%
• Treatment Strategy 33%
• 5-year Survival 33%
• Chemotherapy 33%
• Novel Therapeutics 33%
• Cell-Associated 33%
• Oropharyngeal Squamous Cell Carcinoma (OPSCC) 33%
• Radiotherapy 33%
• Conventional Treatment 33%
• Oral Cavity Cancer 33%
• Neck Tumor 33%
• Immune Therapy 33%
• Combined Modality Therapy 33%
• Locally Advanced 33%
• Specific Mechanisms 33%
• Tumor Immunology 33%
• Immune-suppressive 33%
• Annual Incidence 33%
• Suppression Mechanism 33%
• Immunosuppressive Cells 33%

Medicine and Dentistry

• Head and Neck Squamous Cell Carcinoma 100%
• Head and Neck Cancer 100%
• Immunosuppressive Drug 100%
• Tumor Microenvironment 100%
• Immune Response 66%
• Oral Cancer 33%
• Immunosuppressive Treatment 33%
• Neoplasm 33%
• Survival Rate 33%
• Mediator 33%
• Head and Neck Tumor 33%
• Pharynx Cancer 33%
• Radiation Therapy 33%
• Treatment Modality 33%

Immunology and Microbiology

• Immunosuppressive Drug 100%
• Neck 100%
• Squamous Cell 60%
• Immune Response 40%
• Immunosuppression 20%
• Mediator 20%
• Survival Rate 20%